Vygon monitors provide improvement for ovarian cancer patients
Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019
Read More
Tag: ovarian
Norfolk and Norwich University Hospitals establishes therapy for ovarian cancer patients
Procedure is carried out following the completion of surgery to remove all visible disease
Read More
Lynparza hits target in late stage ovarian cancer trial
he companies announced earlier this month that the drug was also successful in prostate cancer.
Read More
Lynparza ASCO success continues with positive ovarian cancer results
The treatment achieved a 72% objective response rate in patients with previously treated germline BRCA1/2-mutated advanced ovarian cancer.
Read More
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
